Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability

NeuroImage

Volumn 34, Issue 2, 2007, Pages 509-517

  Charil, Arnaud ^a   Dagher, Alain ^a   Lerch, Jason P ^a   Zijdenbos, Alex P ^a   Worsley, Keith J ^a,b   Evans, Alan C ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOANALYSIS; BRAIN CORTEX; BRAIN CORTEX ATROPHY; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; FEMALE; HUMAN; INSULA; MAJOR CLINICAL STUDY; MALE; MOTOR CORTEX; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SENSORY CORTEX; VISUAL CORTEX; WHITE MATTER;

AGED; ATROPHY; CEREBRAL CORTEX; FEMALE; HISTORY, 16TH CENTURY; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 33947219237     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2006.10.006     Document Type: Article

References (39)

1. Anderson V.M., Fox N.C., and Miller D.H. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J. Magn. Reson. Imaging 23 (2006) 605-618
2. Ashburner J., and Friston K.J. Voxel-based morphometry-The methods. NeuroImage 11 (2001) 805-821
3. Bakshi R., Benedict R.H., Bermel R.A., and Jacobs L. Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings. J. Neuroimaging 11 (2001) 129-136
4. Bö L., Vedeler C.A., Nyland H.I., Trapp B.D., and Mork S.J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 62 (2003) 723-732
5. Chard D.T., Griffin C.M., Parker G.J., Kapoor R., Thompson A.J., and Miller D.H. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 125 (2002) 327-337
6. Charil A., Zijdenbos A.P., Taylor J., Boelman C., Worsley K.J., Evans A.C., and Dagher A. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. NeuroImage 19 (2003) 532-544
7. Chen J.T., Narayanan S., Collins D.L., Smith S.M., Matthews P.M., and Arnold D.L. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. NeuroImage 23 (2004) 1168-1175
8. Chung M.K., Worsley K.J., Robbins S., Paus T., Taylor J., Giedd J.N., Rapoport J.L., and Evans A.C. Deformation-based surface morphometry applied to gray matter deformation. NeuroImage 18 (2003) 198-213
9. Collins D.L., Neelin P., Peters T.M., and Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 18 (1994) 192-205
10. Cutter G.R., Baier M.L., Rudick R.A., Cookfair D.L., Fischer J.S., Petkau J., Syndulko K., Weinshenker B.G., Antel J.P., Confavreux C., Ellison G.W., Lublin F., Miller A.E., Rao S.M., Reingold S., Thompson A., and Willoughby E. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122 (1999) 871-882
11. De Stefano N., Matthews P.M., Filippi M., Agosta F., De Luca M., Bartolozzi M.L., Guidi L., Ghezzi A., Montanari E., Cifelli A., Federico A., and Smith S.M. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60 (2003) 1157-1162
12. Eastwood A., and Reingold S. Disappointing results from clinical trial of oral myelin for relapsing-remitting multiple sclerosis. Research and Medical Programs Department News (1997), National Multiple Sclerosis Society, New York, NY
13. Ge Y., Grossman R.I., Udupa J.K., Babb J.S., Nyul L.G., and Kolson D.L. Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter. Radiology 220 (2001) 606-610
14. Geurts J.J., Pouwels P.J., Uitdehaag B.M., Polman C.H., Barkhof F., and Castelijns J.A. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 236 (2005) 254-260
15. Hardmeier M., Wagenpfeil S., Freitag P., Fisher E., Rudick R.A., KooijmansCoutinho M., Clanet M., Radue E.W., Kappos L., and European rIFN beta-1a in Relapsing MS Dose Comparison Trial Study Group. Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis. Arch. Neurol. 60 (2003) 1736-1739
16. Jueptner M., Stephan K.M., Frith C.D., Brooks D.J., Frackowiak R.S., and Passingham R.E. Anatomy of motor learning: I. Frontal cortex and attention to action. J. Neurophysiol. 77 (1997) 1313-1324
17. Kabani N., Le Goualher G., MacDonald D., and Evans A.C. Measurement of cortical thickness using an automated 3-D algorithm: a validation study. NeuroImage 13 (2001) 375-380
18. Kalkers N.F., Ameziane N., Bot J.C., Minneboo A., Polman C.H., and Barkhof F. Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. Arch. Neurol. 59 (2002) 1572-1576
19. Kamber M., Shinghal R., Collins L., Francis G.S., and Evans A.C. Model-based 3D segmentation of multiple sclerosis lesions in magnetic resonance brain images. IEEE Trans. Med. Imag. 14 (1995) 442-453
20. Kim J.S., Singh V., Lee J.K., Lerch J., Ad-Dab'bagh Y., MacDonald D., Lee J.M., Kim S.I., and Evans A.C. Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. NeuroImage 27 (2005) 210-221
21. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
22. Kutzelnigg A., and Lassmann H. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?. J. Neurol. Sci. 245 (2006) 123-126
23. Lerch J.P., and Evans A.C. Cortical thickness analysis examined through power analysis and a population simulation. NeuroImage 24 (2005) 163-173
24. Lerch J.P., Pruessner J.C., Zijdenbos A., Hampel H., Teipel S.J., and Evans A.C. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb. Cortex 15 (2005) 995-1001
25. Lerch J.P., Worsley K., Shaw W.P., Greenstein D.K., Lenroot R.K., Giedd J., and Evans A.C. Mapping anatomical correlations across cerebral cortex (MACACC) using cortical thickness from MRI. NeuroImage 31 (2006) 993-1003
26. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat. Rev., Neurosci. 2 (2001) 417-424
27. Peterson J.W., Bo L., Mork S., Chang A., and Trapp B.D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50 (2001) 389-400
28. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., and Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13 (1983) 227-231
29. Sailer M., Fischl B., Salat D., Tempelmann C., Schonfeld M.A., Busa E., Bodammer N., Heinze H.J., and Dale A. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 126 (2003) 1734-1744
30. Salat D.H., Buckner R.L., Snyder A.Z., Greve D.N., Desikan R.S., Busa E., Morris J.C., Dale A.M., and Fischl B. Thinning of the cerebral cortex in aging. Cereb. Cortex 14 (2004) 721-730
31. Shaw P., Lerch J., Clasen L., Lenroot R., Gogtay N., Evans A., Rapoport J., and Giedd J. Intellectual ability and cortical development in children and adolescents. Nature 440 (2006) 676-679
32. Shaw P., Greenstein D., Lerch J., Sharp W., Clasen L., Evans A., Giedd J., Castellanos F.X., and Rapoport J. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention deficit/hyperactivity disorder. Arch. Gen. Psychiatry 63 (2006) 540-549
33. Sled J.G., Zijdenbos A.P., and Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imag. 17 (1998) 87-97
34. Talairach J., and Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging (1988), Thieme, Stuttgart
35. Vercellino M., Plano F., Votta B., Mutani R., Giordana M.T., and Cavalla P. Grey matter pathology in multiple sclerosis. J. Neuropathol. Exp. Neurol. 64 (2005) 1101-1117
36. Weiner H.L. Oral tolerance for the treatment of autoimmune diseases. Annu. Rev. Med. 48 (1997) 341-351
37. Worsley K.J., Marrett S., Neelin P., Vandal A.C., Friston K.J., and Evans A.C. A unified statistical approach for determining significant signals in images of cerebral activation. Hum. Brain Mapp. 4 (1996) 58-73
38. Worsley K.J., Andermann M., Koulis T., MacDonald D., and Evans A.C. Detecting changes in nonisotropic images. Hum. Brain Mapp. 8 (1999) 98-101
39. Zijdenbos A.P., Forghani R., and Evans A.C. Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis. IEEE Trans. Med. Imag. 21 (2002) 1280-1291